Neuroendocrine Effects of Stress on Immunity in the Elderly: Implications for Inflammatory Disease

Immunology and Allergy Clinics of North America

Volumn 31, Issue 1, 2011, Pages 95-108

  Heffner, Kathi L ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Aging; HPA axis; Inflammation; Inflammatory disease; Older adults; Stress

Indexed keywords

GAMMA INTERFERON; HYDROCORTISONE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 6; PRASTERONE SULFATE;

AGED; AGING; CELLULAR IMMUNITY; CHRONIC STRESS; HUMAN; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE SYSTEM; IMMUNOMODULATION; INFLAMMATORY DISEASE; MENTAL STRESS; NEUROENDOCRINE SYSTEM; NONHUMAN; PHYSICAL STRESS; PHYSIOLOGICAL STRESS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TH1 CELL; TH2 CELL;

AGED; AGED, 80 AND OVER; AGING; CYTOKINES; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMMUNITY; IMMUNOMODULATION; INFLAMMATION; NEUROSECRETORY SYSTEMS; PITUITARY-ADRENAL SYSTEM; STRESS, PSYCHOLOGICAL;

EID: 78649346503     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.iac.2010.09.005     Document Type: Review

References (121)

1. Franceschi C., Bonafe M., Valensin S., et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 2000, 908:244-254.
2. Kiecolt-Glaser J.K., Preacher K.J., MacCallum R.C., et al. Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc Natl Acad Sci U S A 2003, 100:9090-9095.
3. Papanicolaou D.A., Wilder R.L., Manolagas S.C., et al. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 1998, 128:127-137.
4. Elenkov I.J., Iezzoni D.G., Daly A., et al. Cytokine dysregulation, inflammation and well-being. Neuroimmunomodulation 2005, 12:255-269.
5. Hawkley L.C., Cacioppo J.T. Stress and the aging immune system. Brain Behav Immun 2004, 18:114-119.
6. McEwen B.S. Central effects of stress hormones in health and disease: understanding the protective and damaging effects of stress and stress mediators. Eur J Pharmacol 2008, 583:174-185.
7. Bauer M.E. Stress, glucocorticoids and ageing of the immune system. Stress 2005, 8:69-83.
8. Butcher S.K., Lord J.M., Butcher S.K., et al. Stress responses and innate immunity: aging as a contributory factor. Aging Cell 2004, 3:151-160.
9. Ershler W.B., Keller E.T. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med 2000, 51:245-270.
10. Gruenewald T.L., Seeman T.E., Ryff C.D., et al. Combinations of biomarkers predictive of later life mortality. Proc Natl Acad Sci U S A 2006, 103:14158-14163.
11. Harris T.B., Ferrucci L., Tracy R.P., et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 1999, 106:506-512.
12. Black P.H. The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II. Med Hypotheses 2006, 67:879-891.
13. Giunta S. Exploring the complex relations between inflammation and aging (inflamm-aging): anti-inflamm-aging remodelling of inflamm- aging, from robustness to frailty. Inflamm Res 2008, 57:558-563.
14. van Leeuwen M.A., Westra J., Limburg P.C., et al. Clinical significance of interleukin-6 measurement in early rheumatoid arthritis: relation with laboratory and clinical variables and radiological progression in a three year prospective study. Ann Rheum Dis 1995, 54:674-677.
15. Diehl S., Rincon M. The two faces of IL-6 on Th1/Th2 differentiation. Mol Immunol 2002, 39:531-536.
16. Elenkov I.J. Neurohormonal-cytokine interactions: implications for inflammation, common human diseases and well-being. Neurochem Int 2008, 52:40-51.
17. Elenkov I.J., Chrousos G.P. Stress hormones, Th1/Th2 patterns, pro/anti-inflammatory cytokines and susceptibility to disease. Trends Endocrinol Metab 1999, 10:359-368.
18. Marshall G.D., Agarwal S.K., Lloyd C., et al. Cytokine dysregulation associated with exam stress in healthy medical students. Brain Behav Immun 1998, 12:297-307.
19. Rink L., Cakman I., Kirchner H. Altered cytokine production in the elderly. Mech Ageing Dev 1998, 102:199-209.
20. Castle S.C. Clinical relevance of age-related immune dysfunction. Clin Infect Dis 2000, 31:578-585.
21. Glaser R., MacCallum R.C., Laskowski B.F., et al. Evidence for a shift in the Th-1 to Th-2 cytokine response associated with chronic stress and aging. J Gerontol A Biol Sci Med Sci 2001, 56:M477-M482.
22. Elenkov I.J., Kvetnansky R., Hashiramoto A., et al. Low- versus high-baseline epinephrine output shapes opposite innate cytokine profiles: presence of Lewis- and Fischer-like neurohormonal immune phenotypes in humans?. J Immunol 2008, 181:1737-1745.
23. Eskandari F., Webster J.I., Sternberg E.M. Neural immune pathways and their connection to inflammatory diseases. Arthritis Res Ther 2003, 5:251-265.
24. Marshall G.D. Neuroendocrine mechanisms of immune dysregulation: applications to allergy and asthma. Ann Allergy Asthma Immunol 2004, 93:S11-S17.
25. Brydon L., Walker C., Wawrzyniak A., et al. Synergistic effects of psychological and immune stressors on inflammatory cytokine and sickness responses in humans. Brain Behav Immun 2009, 23:217-224.
26. Zhou D., Kusnecov A.W., Shurin M.R., et al. Exposure to physical and psychological stressors elevates plasma interleukin 6: relationship to the activation of hypothalamic-pituitary-adrenal axis. Endocrinology 1993, 133:2523-2530.
27. Straub R.H., Gluck T., Cutolo M., et al. The adrenal steroid status in relation to inflammatory cytokines (interleukin-6 and tumour necrosis factor) in polymyalgia rheumatica. Rheumatology 2000, 39:624-631.
28. Chrousos G.P. Stress and disorders of the stress system. Nat Rev Endocrinol 2009, 5:374-381.
29. Lovallo W.R. Stress & health: biological and psychological interactions 2005, Sage, Thousand Oaks (CA). 2nd edition.
30. Chahal H.S., Drake W.M. The endocrine system and ageing. J Pathol 2007, 211:173-180.
31. Maninger N., Wolkowitz O.M., Reus V.I., et al. Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS). Front Neuroendocrinol 2009, 30:65-91.
32. Ferrari E., Cravello L., Muzzoni B., et al. Age-related changes of the hypothalamic-pituitary-adrenal axis: pathophysiological correlates. Eur J Endocrinol 2001, 144:319-329. European federation of endocrine societies.
33. Goncharova N.D., Lapin B.A. Effects of aging on hypothalamic-pituitary-adrenal system function in non-human primates. Mech Ageing Dev 2002, 123:1191-1201.
34. Born J., Ditschuneit I., Schreiber M., et al. Effects of age and gender on pituitary-adrenocortical responsiveness in humans. Eur J Endocrinol 1995, 132:705-711. European federation of endocrine societies.
35. Seeman T.E., Singer B., Wilkinson C.W., et al. Gender differences in age-related changes in HPA axis reactivity. Psychoneuroendocrinology 2001, 26:225-240.
36. Bauer M.E., Vedhara K., Perks P., et al. Chronic stress in caregivers of dementia patients is associated with reduced lymphocyte sensitivity to glucocorticoids. J Neuroimmunol 2000, 103:84-92.
37. Kumari M., Badrick E., Sacker A., et al. Identifying patterns in cortisol secretion in an older population. Findings from the Whitehall II study. Psychoneuroendocrinology 2010, 35(7):1091-1099.
38. Van Cauter E., Leproult R., Kupfer D.J. Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol. J Clin Endocrinol Metab 1996, 81:2468-2473.
39. Straub R.H., Miller L.E., Scholmerich J., et al. Cytokines and hormones as possible links between endocrinosenescence and immunosenescence. J Neuroimmunol 2000, 109:10-15.
40. Heuser I.J., Gotthardt U., Schweiger U., et al. Age-associated changes of pituitary-adrenocortical hormone regulation in humans: importance of gender. Neurobiol Aging 1994, 15:227-231.
41. Kudielka B.M., Schmidt-Reinwald A.K., Hellhammer D.H., et al. Psychological and endocrine responses to psychosocial stress and dexamethasone/corticotropin-releasing hormone in healthy postmenopausal women and young controls: the impact of age and a two-week estradiol treatment. Neuroendocrinology 1999, 70:422-430.
42. Otte C., Hart S., Neylan T.C., et al. A meta-analysis of cortisol response to challenge in human aging: importance of gender. Psychoneuroendocrinology 2005, 30:80-91.
43. Gotthardt U., Schweiger U., Fahrenberg J., et al. Cortisol, ACTH, and cardiovascular response to a cognitive challenge paradigm in aging and depression. Am J Physiol 1995, 268:R865-R873.
44. Kudielka B.M., Buske-Kirschbaum A., Hellhammer D.H., et al. HPA axis responses to laboratory psychosocial stress in healthy elderly adults, younger adults, and children: impact of age and gender. Psychoneuroendocrinology 2004, 29:83-98.
45. Rohleder N., Kudielka B.M., Hellhammer D.H., et al. Age and sex steroid-related changes in glucocorticoid sensitivity of pro-inflammatory cytokine production after psychosocial stress. J Neuroimmunol 2002, 126:69-77.
46. Nicolson N., Storms C., Ponds R., et al. Salivary cortisol levels and stress reactivity in human aging. J Gerontol A Biol Sci Med Sci 1997, 52:M68-M75.
47. Traustadottir T., Bosch P.R., Matt K.S. The HPA axis response to stress in women: effects of aging and fitness. Psychoneuroendocrinology 2005, 30:392-402.
48. Traustadottir T., Bosch P.R., Matt K.S. Gender differences in cardiovascular and hypothalamic- pituitary-adrenal axis responses to psychological stress in healthy older adult men and women. Stress: The international journal on the biology of stress 2003, 6:133-140.
49. Kudielka B.M., Hellhammer D.H., Wust S. Why do we respond so differently? Reviewing determinants of human salivary cortisol responses to challenge. Psychoneuroendocrinology 2009, 34:2-18.
50. Stroud L.R., Salovey P., Epel E.S. Sex differences in stress responses: social rejection versus achievement stress. Biol Psychiatry 2002, 52:318-327.
51. Heffner K.L., Kiecolt-Glaser J.K., Loving T.J., et al. Spousal support satisfaction as a modifier of physiological responses to marital conflict in younger and older couples. J Behav Med 2004, 27:233-254.
52. Wilkinson C.W., Petrie E.C., Murray S.R., et al. Human glucocorticoid feedback inhibition is reduced in older individuals: evening study. J Clin Endocrinol Metab 2001, 86:545-550.
53. Bornstein S.R., Engeland W.C., Ehrhart-Bornstein M., et al. Dissociation of ACTH and glucocorticoids. Trends Endocrinol Metab 2008, 19:175-180.
54. DeRijk R.H., Petrides J., Deuster P., et al. Changes in corticosteroid sensitivity of peripheral blood lymphocytes after strenuous exercise in humans. J Clin Endocrinol Metab 1996, 81:228-235.
55. Daun J.M., Ball R.W., Cannon J.G. Glucocorticoid sensitivity of interleukin-1 agonist and antagonist secretion: the effects of age and gender. Am J Physiol Regul Integr Comp Physiol 2000, 278:R855-R862.
56. Miller G.E., Chen E., Fok A.K., et al. Low early-life social class leaves a biological residue manifested by decreased glucocorticoid and increased proinflammatory signaling. Proc Natl Acad Sci U S A 2009, 106:14716-14721.
57. Miller G.E., Cohen S., Ritchey A.K. Chronic psychological stress and the regulation of pro-inflammatory cytokines: a glucocorticoid-resistance model. Health Psychol 2002, 21:531-541.
58. Rohleder N., Wolf J.M., Kirschbaum C. Glucocorticoid sensitivity in humans-interindividual differences and acute stress effects. Stress 2003, 6:207-222.
59. Chrousos G.P., Detera-Wadleigh S.D., Karl M. Syndromes of glucocorticoid resistance. Ann Intern Med 1993, 119:1113-1124.
60. Rhen T., Cidlowski J.A. Antiinflammatory action of glucocorticoids-new mechanisms for old drugs. N Engl J Med 2005, 353:1711-1723.
61. Heijnen C.J. Receptor regulation in neuroendocrine-immune communication: current knowledge and future perspectives. Brain Behav Immun 2007, 21:1-8.
62. Barnes P.J. Mechanisms and resistance in glucocorticoid control of inflammation. J Steroid Biochem Mol Biol 2010, 120(2-3):76-85.
63. Rosewicz S., McDonald A.R., Maddux B.A., et al. Mechanism of glucocorticoid receptor down-regulation by glucocorticoids. J Biol Chem 1988, 263:2581-2584.
64. Webster J.C., Oakley R.H., Jewell C.M., et al. Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative beta isoform: a mechanism for the generation of glucocorticoid resistance. Proc Natl Acad Sci U S A 2001, 98:6865-6870.
65. Agarwal S.K., Marshall G.D. Dexamethasone promotes type 2 cytokine production primarily through inhibition of type 1 cytokines. J Interferon Cytokine Res 2001, 21:147-155.
66. Elenkov I.J., Chrousos G.P. Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann N Y Acad Sci 2002, 966:290-303.
67. Buske-Kirschbaum A., Fischbach S., Rauh W., et al. Increased responsiveness of the hypothalamus-pituitary-adrenal (HPA) axis to stress in newborns with atopic disposition. Psychoneuroendocrinology 2004, 29:705-711.
68. Wright R.J., Finn P., Contreras J.P., et al. Chronic caregiver stress and IgE expression, allergen-induced proliferation, and cytokine profiles in a birth cohort predisposed to atopy. J Allergy Clin Immunol 2004, 113:1051-1057.
69. Kiecolt-Glaser J.K., Heffner K.L., Glaser R., et al. How stress and anxiety can alter immediate and late phase skin test responses in allergic rhinitis. Psychoneuroendocrinology 2009, 34:670-680.
70. Buske-Kirschbaum A., Geiben A., Hollig H., et al. Altered responsiveness of the hypothalamus-pituitary-adrenal axis and the sympathetic adrenomedullary system to stress in patients with atopic dermatitis. J Clin Endocrinol Metab 2002, 87:4245-4251.
71. Orentreich N., Brind J.L., Rizer R.L., et al. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 1984, 59:551-555.
72. Orentreich N., Brind J.L., Vogelman J.H., et al. Long-term longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal men. J Clin Endocrinol Metab 1992, 75:1002-1004.
73. Vermeulen A. Dehydroepiandrosterone sulfate and aging. Ann N Y Acad Sci 1995, 774:121-127.
74. Hornsby P.J. Biosynthesis of DHEAS by the human adrenal cortex and its age-related decline. Ann N Y Acad Sci 1995, 774:29-46.
75. Parker C.R., Mixon R.L., Brissie R.M., et al. Aging alters zonation in the adrenal cortex of men. J Clin Endocrinol Metab 1997, 82:3898-3901.
76. Arlt W., Hewison M. Hormones and immune function: implications of aging. Aging Cell 2004, 3:209-216.
77. Kahonen M.H., Tilvis R.S., Jolkkonen J., et al. Predictors and clinical significance of declining plasma dehydroepiandrosterone sulfate in old age. Aging 2000, 12:308-314.
78. Tannenbaum C., Barrett-Connor E., Laughlin G.A., et al. A longitudinal study of dehydroepiandrosterone sulphate (DHEAS) change in older men and women: the rancho bernardo study. Eur J Endocrinol 2004, 151:717-725. European federation of endocrine societies.
79. Mazat L., Lafont S., Berr C., et al. Prospective measurements of dehydroepiandrosterone sulfate in a cohort of elderly subjects: relationship to gender, subjective health, smoking habits, and 10-year mortality. Proc Natl Acad Sci U S A 2001, 98:8145-8150.
80. Izawa S., Sugaya N., Shirotsuki K., et al. Salivary dehydroepiandrosterone secretion in response to acute psychosocial stress and its correlations with biological and psychological changes. Biol Psychol 2008, 79:294-298.
81. Morgan C.A., Southwick S., Hazlett G., et al. Relationships among plasma dehydroepiandrosterone sulfate and cortisol levels, symptoms of dissociation, and objective performance in humans exposed to acute stress. Arch Gen Psychiatry 2004, 61:819-825.
82. Maninger N., Capitanio J.P., Mason W.A., et al. Acute and chronic stress increase DHEAS concentrations in rhesus monkeys. Psychoneuroendocrinology 2010, 35(7):1055-1062.
83. Parker C.R., Slayden S.M., Azziz R., et al. Effects of aging on adrenal function in the human: responsiveness and sensitivity of adrenal androgens and cortisol to adrenocorticotropin in premenopausal and postmenopausal women. J Clin Endocrinol Metab 2000, 85:48-54.
84. Kalimi M., Shafagoj Y., Loria R., et al. Anti-glucocorticoid effects of dehydroepiandrosterone (DHEA). Mol Cell Biochem 1994, 131:99-104.
85. Hechter O., Grossman A., Chatterton R.T. Relationship of dehydroepiandrosterone and cortisol in disease. Med Hypotheses 1997, 49:85-91.
86. Daynes R.A., Araneo B.A., Ershler W.B., et al. Altered regulation of IL-6 production with normal aging. Possible linkage to the age-associated decline in dehydroepiandrosterone and its sulfated derivative. J Immunol 1993, 150:5219-5230. (Baltimore Md: 1950).
87. Padgett D.A., Loria R.M. Endocrine regulation of murine macrophage function: effects of dehydroepiandrosterone, androstenediol, and androstenetriol. J Neuroimmunol 1998, 84:61-68.
88. Catania R.A., Angele M.K., Ayala A., et al. Dehydroepiandrosterone restores immune function following trauma-haemorrhage by a direct effect on T lymphocytes. Cytokine 1999, 11:443-450.
89. Suzuki T., Suzuki N., Daynes R.A., et al. Dehydroepiandrosterone enhances IL2 production and cytotoxic effector function of human T cells. Clin Immunol Immunopathol 1991, 61:202-211.
90. Gordon C.M., LeBoff M.S., Glowacki J. Adrenal and gonadal steroids inhibit IL-6 secretion by human marrow cells. Cytokine 2001, 16:178-186.
91. Loria R.M. Beta-androstenes and resistance to viral and bacterial infections. Neuroimmunomodulation 2009, 16:88-95.
92. Kovacs E.J., Duffner L.A., Plackett T.P. Immunosuppression after injury in aged mice is associated with a TH1-TH2 shift, which can be restored by estrogen treatment. Mech Ageing Dev 2004, 125:121-123.
93. Kovacs E.J., Plackett T.P., Witte P.L. Estrogen replacement, aging, and cell-mediated immunity after injury. J Leukoc Biol 2004, 76:36-41.
94. Gilliver S. Sex steroids as inflammatory regulators. J Steroid Biochem Mol Biol 2010, 120(2-3):105-115.
95. Delpedro A.D., Barjavel M.J., Mamdouh Z., et al. Activation of human monocytes by LPS and DHEA. J Interferon Cytokine Res 1998, 18:125-135.
96. Khorram O., Vu L., Yen S.S. Activation of immune function by dehydroepiandrosterone (DHEA) in age-advanced men. J Gerontol A Biol Sci Med Sci 1997, 52:M1-M7.
97. Casson P.R., Andersen R.N., Herrod H.G., et al. Oral dehydroepiandrosterone in physiologic doses modulates immune function in postmenopausal women. Am J Obstet Gynecol 1993, 169:1536-1539.
98. Dillon J.S. Dehydroepiandrosterone, dehydroepiandrosterone sulfate and related steroids: their role in inflammatory, allergic and immunological disorders. Curr Drug Targets Inflamm Allergy 2005, 4:377-385.
99. Bauer M.E., Jeckel C.M., Luz C. The role of stress factors during aging of the immune system. Ann N Y Acad Sci 2009, 1153:139-152.
100. Esler M., Kaye D., Thompson J., et al. Effects of aging on epinephrine secretion and regional release of epinephrine from the human heart. J Clin Endocrinol Metab 1995, 80:435-442.
101. Iwase S., Mano T., Watanabe T., et al. Age-related changes of sympathetic outflow to muscles in humans. J Gerontol 1991, 46:M1-M5.
102. Christensen N.J., Jensen E.W. Effect of psychosocial stress and age on plasma norepinephrine levels: a review. Psychosom Med 1994, 56:77-83.
103. Seals D.R., Esler M.D. Human ageing and the sympathoadrenal system. J Physiol 2000, 528:407-417.
104. Ng A.V., Callister R., Johnson D.G., et al. Age and gender influence muscle sympathetic nerve activity at rest in healthy humans. Hypertension 1993, 21:498-503.
105. Kudielka B.M., Schmidt-Reinwald A.K., Hellhammer D.H., et al. Psychosocial stress and HPA functioning: no evidence for a reduced resilience in healthy elderly men. Stress 2000, 3:229-240.
106. Esler M., Lambert G., Kaye D., et al. Influence of ageing on the sympathetic nervous system and adrenal medulla at rest and during stress. Biogerontology 2002, 3:45-49.
107. Franco-Morselli R., Elghozi J.L., Joly E., et al. Increased plasma adrenaline concentrations in benign essential hypertension. Br Med J 1977, 2:1251-1254.
108. Weidmann P., Beretta-Piccoli C., Ziegler W.H., et al. Age versus urinary sodium for judging renin, aldosterone, and catecholamine levels: studies in normal subjects and patients with essential hypertension. Kidney Int 1978, 14:619-628.
109. Palmer G.J., Ziegler M.G., Lake C.R. Response of norepinephrine and blood pressure to stress increases with age. J Gerontol 1978, 33:482-487.
110. Aslan S., Nelson L., Carruthers M., et al. Stress and age effects on catecholamines in normal subjects. J Psychosom Res 1981, 25:33-41.
111. Mazzeo R.S., Rajkumar C., Jennings G., et al. Norepinephrine spillover at rest and during submaximal exercise in young and old subjects. J Appl Physiol 1997, 82:1869-1874.
112. Friedman E.M., Irwin M.R. Modulation of immune cell function by the autonomic nervous system. Pharmacol Ther 1997, 74:27-38.
113. Nance D.M., Sanders V.M. Autonomic innervation and regulation of the immune system (1987-2007). Brain Behav Immun 2007, 21:736-745.
114. Callahan T.A., Moynihan J.A. Contrasting pattern of cytokines in antigen- versus mitogen-stimulated splenocyte cultures from chemically denervated mice. Brain Behav Immun 2002, 16:764-773.
115. Salicru A.N., Sams C.F., Marshall G.D. Cooperative effects of corticosteroids and catecholamines upon immune deviation of the type-1/type-2 cytokine balance in favor of type-2 expression in human peripheral blood mononuclear cells. Brain Behav Immun 2007, 21:913-920.
116. Straub R.H., Cutolo M., Zietz B., et al. The process of aging changes the interplay of the immune, endocrine and nervous systems. Mech Ageing Dev 2001, 122:1591-1611.
117. Kiecolt-Glaser J.K., Glaser R., Gravenstein S., et al. Chronic stress alters the immune response to influenza virus vaccine in older adults. Proc Natl Acad Sci U S A 1996, 93:3043-3047.
118. Besedovsky H., Sorkin E., Felix D., et al. Hypothalamic changes during the immune response. Eur J Immunol 1977, 7:323-325.
119. Pawelec G., Larbi A., Pawelec G., et al. Immunity and ageing in man: annual review 2006/2007. Exp Gerontol 2008, 43:34-38.
120. McEwen B.S. Sex, stress and the hippocampus: allostasis, allostatic load and the aging process. Neurobiol Aging 2002, 23:921-939.
121. Seeman T.E., McEwen B.S., Rowe J.W., et al. Allostatic load as a marker of cumulative biological risk: MacArthur studies of successful aging. Proc Natl Acad Sci U S A 2001, 98:4770-4775.